After many years of success, EvidenceNetwork.ca is no longer in operation. We would like to thank everyone who has contributed to the organization over the past decade including our dedicated researchers, newspaper editors, readers and funders. However, now it is time to move onto new ways of looking at knowledge mobilization and policy. Should you have any questions, please feel free to contact Shannon Sampert at s.sampert@uwinnipeg.ca.

It is time to talk about the overuse of antipsychotics among adults with developmental disabilities

Inappropriate prescribing of antipsychotic medications — drugs like Risperdal, Zyprexa and Abilify — to seniors, especially those in long-term care with conditions like dementia, has been a hot topic of discussion across Canada in recent years. We have also increasingly heard about the high numbers of these medications being prescribed to children and youth with […]

Canada needs a comprehensive strategy to improve prescription drug safety for seniors

Four years ago, at age 84, my dad survived a severe stroke. The downside is that during his hospital stay this otherwise fit person was put on a drug regimen and has been taking nine prescription drugs a day ever since.

Understanding the opioids crisis in Canada

North America is grappling with an opioids epidemic. British Columbia has even declared a public health emergency because of a significant increase in opioid-related overdoses and deaths. Dr. David Juurlink, Head of the Division of Clinical Pharmacology and Toxicology at the University of Toronto, and Tara Gomes, Epidemiologist and Scientist at St. Michael’s Hospital and […]